GAD1 and prostate cancer: However, the clinical significance of GAD1 in castrate-resistant prostate cancer remains to be clarified, as the number of GAD1-overexpressing prostate cancers identified in the public databases were small and could not be accurately correlated with castrate-resistant disease.